Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNRISE: Rituximab Retreatment in RA
NCT00266227Phase 3Completed
- Sponsor
- Genentech
- Start
- Jan 2006
- Primary completion
- Oct 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by Genentech. Started Jan 2006; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00266227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266227.